Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Related structures:
AlphaFold database: E9B3E5
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity | 6 | 2 |
GO:0016289 | CoA hydrolase activity | 5 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0016790 | thiolester hydrolase activity | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 135 | 137 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 92 | 94 | PF00082 | 0.549 |
DEG_Nend_UBRbox_2 | 1 | 2 | PF02207 | 0.695 |
DOC_CKS1_1 | 94 | 99 | PF01111 | 0.549 |
DOC_MAPK_gen_1 | 53 | 60 | PF00069 | 0.549 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.549 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.549 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 93 | 98 | PF00397 | 0.269 |
LIG_14-3-3_CanoR_1 | 136 | 142 | PF00244 | 0.549 |
LIG_14-3-3_CanoR_1 | 162 | 166 | PF00244 | 0.793 |
LIG_14-3-3_CanoR_1 | 21 | 30 | PF00244 | 0.549 |
LIG_Actin_WH2_2 | 41 | 57 | PF00022 | 0.549 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.549 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.322 |
LIG_FHA_2 | 155 | 161 | PF00498 | 0.719 |
LIG_FHA_2 | 31 | 37 | PF00498 | 0.549 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.549 |
LIG_Integrin_RGD_1 | 107 | 109 | PF01839 | 0.549 |
LIG_LIR_Gen_1 | 109 | 117 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 109 | 113 | PF02991 | 0.549 |
LIG_SH2_CRK | 110 | 114 | PF00017 | 0.549 |
LIG_SH2_NCK_1 | 110 | 114 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.549 |
LIG_SH3_3 | 24 | 30 | PF00018 | 0.549 |
LIG_SUMO_SIM_anti_2 | 148 | 153 | PF11976 | 0.549 |
LIG_SUMO_SIM_anti_2 | 72 | 77 | PF11976 | 0.549 |
LIG_SUMO_SIM_par_1 | 71 | 77 | PF11976 | 0.549 |
LIG_SUMO_SIM_par_1 | 84 | 89 | PF11976 | 0.322 |
LIG_WRC_WIRS_1 | 103 | 108 | PF05994 | 0.549 |
MOD_CDK_SPxxK_3 | 46 | 53 | PF00069 | 0.549 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.805 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.549 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.549 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.462 |
MOD_CK2_1 | 30 | 36 | PF00069 | 0.549 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.549 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.549 |
MOD_GlcNHglycan | 64 | 68 | PF01048 | 0.549 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.375 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.549 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.549 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.549 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.549 |
MOD_NEK2_2 | 161 | 166 | PF00069 | 0.791 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.791 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.549 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.375 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.791 |
MOD_Plk_4 | 98 | 104 | PF00069 | 0.549 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.549 |
MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.549 |
MOD_ProDKin_1 | 93 | 99 | PF00069 | 0.269 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.549 |
TRG_NES_CRM1_1 | 120 | 134 | PF08389 | 0.549 |
TRG_Pf-PMV_PEXEL_1 | 55 | 59 | PF00026 | 0.549 |